Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-52012

Composite map
Single-particle
2.5 Å
EMD-52012 Deposition: 05/11/2024
Map released: 04/06/2025
Last modified: 04/06/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-52012

cryo-EM structure of inactive human arginine-vasopressin (AVP) V2 receptor (V2R) with Mambaquaretin1 K39A (MQK39A)

EMD-52012

Composite map
Single-particle
2.5 Å
EMD-52012 Deposition: 05/11/2024
Map released: 04/06/2025
Last modified: 04/06/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Dendroaspis angusticeps
Sample: Inactive V2R-bril bound to tolvaptan stabillized with anti-BRIL Fab and anti-BRIL Fab Nanobody
Fitted models: 9hb3

Deposition Authors: Bous J , Fouillen A , Couvineau P , Orcel H , Mary C, Mendre C , Schulte G , Granier S , Gilles N , Mouillac B
Inactive structures of the vasopressin V2 receptor reveal distinct binding modes for Tolvaptan and Mambaquaretin toxin.
Fouillen A , Bous J , Couvineau P , Orcel H , Mary C, Lafleur L, Pierre T, Mendre C , Gilles N , Schulte G , Granier S , Mouillac B
(2025) Nat Commun , 16 , 3899 - 3899
PUBMED: 40274867
DOI: doi:10.1038/s41467-025-59114-5
ISSN: 2041-1723